Skip to main content
Techno Medica Co., Ltd. logo

Techno Medica Co., Ltd. - Investor Relations & Filings

Listed
Ticker · 6678 ISIN · JP3545110003 T Manufacturing
Filings indexed 114 across all filing types
Latest filing 2024-05-09 Regulatory Filings
Country JP Japan
Listing T 6678 · 1 venue

About Techno Medica Co., Ltd.

https://www.technomedica.co.jp/t01/Engl…

Techno Medica Co., Ltd. specializes in the research, development, manufacturing, and sale of in-vitro diagnostic (IVD) analyzers and automated pre-analytical systems for clinical laboratories. The company provides solutions that automate the workflow for blood and urine testing, covering processes from test registration and pre-analysis to patient identification and specimen transfer management. Its product portfolio includes next-generation IVD analyzers, such as electrolyte analyzers, and it is a leading manufacturer in the test tube market. The company focuses on delivering innovative products and services designed to enhance the efficiency, accuracy, and safety of laboratory diagnostics.

Recent filings

Filing Released Lang Actions
2024年3月期 決算短信〔日本基準〕(非連結)
Regulatory Filings
2024-05-09 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text contains the header "第3四半期報告書" (Third Quarter Report) and specifies the period covered: "第37期第3四半期(自2023年10月1日 至2023年12月31日)". It also includes a confirmation statement regarding the appropriateness of the quarterly report's contents, filed with the Kanto Local Finance Bureau. This structure strongly indicates a comprehensive financial report for an interim period shorter than a year, which corresponds to the definition of an Interim / Quarterly Report (IR). The document length is very short (567 chars), but the content is the substance of the report confirmation itself, not just an announcement of publication, making IR more appropriate than RPA/RNS, although it is a confirmation document related to the filing.
2024-02-13 Japanese
四半期報告書-第37期第3四半期(2023/10/01-2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (第3四半期報告書) for Techno Medica Co., Ltd. for the period ending December 31, 2023. It contains detailed financial statements (balance sheet, income statement), notes to financial statements, and management analysis. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-02-13 Japanese
2024年3月期 第3四半期決算短信〔日本基準〕(非連結)
Regulatory Filings
2024-02-07 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of the Second Quarter Report (Interim Report). While it references the quarterly report, the document itself is a formal regulatory filing confirming the validity of the financial statements for the period ending September 30, 2023. Since it is a specific regulatory filing required by Japanese law for financial reporting, and does not fit into the 'Interim Report' (IR) category itself (which would be the full report), it is best classified as a Regulatory Filing (RNS).
2023-11-10 Japanese
四半期報告書-第37期第2四半期(2023/07/01-2023/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Techno Medica Co., Ltd., covering the second quarter of the fiscal year ending March 31, 2024. It contains detailed financial statements (balance sheet, income statement), management analysis (MDA), and regulatory disclosures required under the Financial Instruments and Exchange Act of Japan. As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. H1 2024
2023-11-10 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.